(Q39029116)

8 September 2017

title

Alternative delivery of a thermostable inactivated polio vaccine (English)

1 reference

8 September 2017

5

Clemens Löwik

1 reference

8 September 2017

4

Ivo Que

1 reference

8 September 2017

6

Gideon Kersten

1 reference

8 September 2017

2

Ivo Ploemen

1 reference

8 September 2017

Heleen Kraan

1

1 reference

8 September 2017

Gijsbert van de Wijdeven

series ordinal

3

1 reference

8 September 2017

Jean-Pierre Amorij

series ordinal

7

1 reference

8 September 2017

language of work or name

English

0 references

publication date

13 March 2015

1 reference

8 September 2017

1 reference

8 September 2017

volume

33

1 reference

8 September 2017

issue

17

1 reference

8 September 2017

page(s)

2030-2037

1 reference

Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Buccal and sublingual vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Towards tailored vaccine delivery: needs, challenges and perspectives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Intranasal formulations: promising strategy to deliver vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Syringe free vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles provides strong and prolonged protection against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Bioneedles as vaccine carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Bioneedles as alternative delivery system for hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Solid bioneedle-delivered influenza vaccines are highly thermostable and induce both humoral and cellular immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Phase 1 clinical study with Bioneedles, a delivery platform for biopharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Development of thermostable lyophilized inactivated polio vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Multivariate data analysis on historical IPV production data for better process understanding and future improvements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Development of a fast ELISA for quantifying polio D-antigen in in-process samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Some experiments on freezedrying of inactivated poliomyelitis-vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

The modification of poliovirus antigens by heat and ultraviolet light

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

The preparation of specific immune sera against type 3 poliovirus D-antigen and C-antigen and the demonstration of two C-antigenic components in vaccine strain populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Towards an understanding of the adjuvant action of aluminium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Biodistribution of vaccines comprised of hydrophobically-modified poly(γ-glutamic acid) nanoparticles and antigen proteins using fluorescence imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

A mucosal adjuvant for the inactivated poliovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Chitosan as an adjuvant for poliovaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.011

10.1016/J.VACCINE.2015.03.011

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference